Research Update: CVS CreditWatch Revised To Negative From Developing After Caremark Merger Proposal Changes - S&P Global Ratings’ Credit Research

Research Update: CVS CreditWatch Revised To Negative From Developing After Caremark Merger Proposal Changes

Research Update: CVS CreditWatch Revised To Negative From Developing After Caremark Merger Proposal Changes - S&P Global Ratings’ Credit Research
Research Update: CVS CreditWatch Revised To Negative From Developing After Caremark Merger Proposal Changes
Published Mar 08, 2007
644 words — Published Mar 08, 2007
Price US$ 225.00  |  Buy this Report Now

About This Report

  
Abstract:

On March 8, 2007, Standard&Poor's Ratings Services revised the CreditWatch implications on CVS Corp.'s long-term ratings, including the 'BBB+' corporate credit rating, to negative from developing. The ratings were initially placed on CreditWatch on Nov. 2, 2006, when Woonsocket, R.I.-based CVS announced a definitive agreement to merge with Caremark Rx Inc. (BBB/Stable/--). The 'A-2' short-term and the CP ratings on CVS are not on CreditWatch. The revision of the CreditWatch listing follows CVS' and Caremark's fourth proposal for the structure of their proposed merger. Under the revised terms, Caremark's shareholders will receive a special one-time cash dividend of $7.50 per share, about $3.23 billion. The combined company will also repurchase 150 million common shares at a fixed price

  
Brief Excerpt:

RESEARCH Research Update: CVS CreditWatch Revised To Negative From Developing After Caremark Merger Proposal Changes Publication date: 08-Mar-2007 Rationale On March 8, 2007, Standard & Poor's Ratings Services revised the CreditWatch...

  
Report Type:

Research Update

Ticker
Issuer
GICS
Health Care Services (35102015)
Sector
Global Issuers , Structured Finance
Country
Region
Format:
PDF Adobe Acrobat
Buy Now

S&P Global Ratings’ Credit Research—S&P Global Ratings’ credit research provides analysis on issuers and debt obligations of corporations, states and municipalities, financial institutions, insurance companies and sovereign governments. S&P Global Ratings also offers insight into the credit risk of structured finance deals, providing an independent view of credit risk associated with a growing array of debt-securitized instruments.

About the Author


Cite this Report

  
MLA:
S&P Global Ratings’ Credit Research. "Research Update: CVS CreditWatch Revised To Negative From Developing After Caremark Merger Proposal Changes" Mar 08, 2007. Alacra Store. May 06, 2025. <http://www.alacrastore.com/s-and-p-credit-research/Research-Update-CVS-CreditWatch-Revised-To-Negative-From-Developing-After-Caremark-Merger-Proposal-Changes-565864>
  
APA:
S&P Global Ratings’ Credit Research. (). Research Update: CVS CreditWatch Revised To Negative From Developing After Caremark Merger Proposal Changes Mar 08, 2007. New York, NY: Alacra Store. Retrieved May 06, 2025 from <http://www.alacrastore.com/s-and-p-credit-research/Research-Update-CVS-CreditWatch-Revised-To-Negative-From-Developing-After-Caremark-Merger-Proposal-Changes-565864>
  
US$ 225.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Residential Mortgage-Backed Securities from one place.